论文部分内容阅读
目的 总结分析乳腺癌患者临床病理特征与磁共振成像强化率关系.方法 以我院收治的80例经病理确诊的乳腺癌患者为研究对象,对所有患者进行磁共振成像检查,回顾分析不同患者临床病理特征与磁共振成像强化率之间的关系.结果 注射对比剂后不同时间对应的MRI强化率从05min到4min呈现出上升趋势,不同肿瘤大小的乳腺癌病灶在注射对比剂后不同时间的强化率、乳腺癌临床分期以及不同分子分型等方面与开始注射对比剂相比较存在较大差异性(P<005),具有统计学意义.结论 乳腺癌患者病灶的大小、临床分期以及分子分型等都会影响到磁共振成像强化率,通过磁共振强化率变化可对乳腺癌患者的临床诊断提供参考.
Objective To summarize the relationship between clinicopathological features and enhancement rate of MRI in breast cancer patients.Methods Totally 80 patients with pathologically diagnosed breast cancer who were treated in our hospital were enrolled in this study.All the patients were examined by magnetic resonance imaging and retrospectively analyzed the clinical features of different patients Pathological features and MRI enhancement rate.Results MRI enhancement rate corresponding to different time after injection of contrast agent showed an upward trend from 05min to 4min.The different tumor size of breast lesions in different time after injection of contrast agent enhanced Rate, clinical stage of breast cancer and different molecular typing and other aspects of the injection of contrast agent there is a significant difference (P <005), with statistical significance.Conclusion The size of breast lesions, clinical stage and molecular typing Will affect the MRI enhancement rate, through the magnetic resonance rate change can provide a reference for the clinical diagnosis of breast cancer patients.